
The past decade has seen significant advances in stroke prevention. These advances include new antithrombotic agents, new options for dyslipidemia treatment, and novel techniques for surgical stroke prevention. In addition, there is greater recognition of the benefits of multifaceted interventions, including the role of physical activity and dietary modification. However, despite these advances, the ageing of the population and the high prevalence of key vascular risk factors pose challenges to reducing the burden of stroke. This paper outlines current approaches to preventing cardioembolic, cryptogenic, atherosclerotic, and small vessel disease stroke using a cause-based framework. Particular emphasis is given to recent trials of antithrombotic agents, including studies that have tested combination treatments and responses according to genetic factors.
Like
Save
Share